1
|
Trojani V, Fioroni F, Versari A, Iori M. Evaluation of a novel data-driven respiratory gating technique in PET/CT exams. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00039-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
2
|
Abstract
Peptide receptor radionuclide therapy (PRRT) has been strengthened since the publication of NETTER-1. Nevertheless, the correct positioning in the therapeutic algorithm is debated, and no optimal sequence has yet been standardized. Possible criteria to predict the response to PRRT in neuroendocrine tumors (NET) have been proposed. The aim of this review is to define the perfect identity of the eligible patient who can mostly benefit from this therapy. Possible predictive criteria which have been analysed were: primary tumor site, grading, tumor burden, FDG PET and 68Ga-PET uptake. Primary tumor site and 68Ga-PET uptake do not play a pivotal role in predicting the response, while tumor burden, FDG PET uptake and grading seem to represent predictive/prognostic factors for response to PRRT. The heterogeneity in trial designs, patient populations, type of radionuclides, previous therapies and measurement of outcomes, inevitably limits the strength of our conclusions, therefore care must be taken in applying these results to clinical practice. In conclusion, the perfect patient, selected by 68Ga-PET uptake, will likely have a relatively limited liver tumor burden, a ki67 index <20% and will respond to PRRT irrespective to primary tumor. Nevertheless, we have mostly prognostic than predictive factors to predict the efficacy of PRRT in individual patients, while a promising tool could be the NETest. However, to date, the identikit of the perfect patient for PRRT is a puzzle without some pieces and still we cannot disregard a multidisciplinary discussion of the individual case to select the patients who will mostly benefit from PRRT.
Collapse
Affiliation(s)
- M Albertelli
- Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
- Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DiMI) and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy
| | - A Dotto
- Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
- Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DiMI) and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy
| | - C Di Dato
- Endocrinology, Department of Experimental Medicine, "Sapienza", University of Rome, Rome, Italy
| | - P Malandrino
- Endocrinology, Department of Clinical and Experimental Medicine, Garibaldi-Nesima Medical Center, University of Catania, Catania, Italy
| | - R Modica
- Endocrinology, Department of Clinical Medicine and Surgery, "Federico II" University of Napoli, Napoli, Italy
| | - A Versari
- Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - A Colao
- Endocrinology, Department of Clinical Medicine and Surgery, "Federico II" University of Napoli, Napoli, Italy
| | - D Ferone
- Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
- Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DiMI) and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy
| | - A Faggiano
- Endocrinology, Department of Experimental Medicine, "Sapienza", University of Rome, Rome, Italy.
- Depart. of Experimental Medicine, Division of Medical Physiopathology Sapienza University of Rome Viale del Policlinico 155, 00161, Rome, Italy.
| | | |
Collapse
|
3
|
Montevecchi G, Masino F, Versari A, Ricci A, Nigro G, Antonelli A. Effect of Kaolin/Defoliation Combined with Dry Ice on Lambrusco Red Wine Production to Constrain the Effects of Climate Change. S AFR J ENOL VITIC 2021. [DOI: 10.21548/42-2-4436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Since viticulture is affected considerably by climate change, it is imperative to encourage research on newstrategies in order to constrain these critical effects on the composition of berries and the quality of wines.A multi-strategy approach composed of (i) kaolin application on foliage, (ii) late tree defoliation and (iii)cryomaceration of grapes with dry ice was evaluated in the production of Lambrusco Salamino wines.Physical, chemical and sensory analyses were carried out on the sample set, including the control wines.In general, cryomaceration with dry ice proved to be a winning choice to lower alcoholic strength (roughly5%). In addition, the wines showed an increase in anthocyanin content by approximately 17%, while thecontent of catechins, flavanols and hydroxycinnamic acids decreased. Consistent with the increase in theanthocyanin content, an increase in colour indices and sensory colour intensity scores was observed. As forthe aromatic profile, 2-phenylethanol showed an increase of approximately 18% in the treated wines while,in parallel, a lower content of C6 alcohols and volatile fatty acids was observed. The multiple adaptationstrategies put in place in the present study show an alternative way to mitigate the severe effects of climatechange on wine production, and to face changing consumer demands.
Collapse
|
4
|
Durmo R, Ségolèn Cottereau A, Rebaud L, Nioche C, Ruffini A, Fioroni F, Meignan M, Buvat I, Merli F, Versari A, Luminari S. PROGNOSTIC ROLE OF LESION DISSEMINATION FEATURE (DMAX) CALCULATED ON BASELINE PET/CT IN HODGKIN LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.20_2879] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- R Durmo
- University of Modena and Reggio Emilia PhD program in Clinical and Experimental Medicine (CEM) Modena Italy
| | - A Ségolèn Cottereau
- Cochin Hospital, AP‐HP University of Paris Department of Nuclear Medicine Paris France
| | - L Rebaud
- UMR 1288 Université Paris Saclay/Inserm/Institut Curie, LITO laboratory Orsay France
| | - C Nioche
- UMR 1288 Université Paris Saclay/Inserm/Institut Curie, LITO laboratory Orsay France
| | - A Ruffini
- Grade Onlus Hematology Unit Reggio Emilia Italy
| | - F Fioroni
- AUSL‐IRCCS of Reggio Emilia Medical Physics Reggio Emilia Italy
| | - M Meignan
- Henri Mondor University Hospital AP‐HP, University Paris East Lusa Imaging, Creteil France
| | - I Buvat
- UMR 1288 Université Paris Saclay/Inserm/Institut Curie, LITO laboratory Orsay France
| | - F Merli
- AUSL‐IRCCS of Reggio Emilia Hematology Unit Reggio Emilia Italy
| | - A Versari
- AUSL‐IRCCS of Reggio Emilia Nuclear Medicine Reggio Emilia Italy
| | - S Luminari
- AUSL‐IRCCS of Reggio Emilia Hematology Unit Reggio Emilia Italy
| |
Collapse
|
5
|
Luminari S, Galimberti S, Versari A, Tucci A, Boccomini C, Farina L, Zaja F, Marcheselli L, Ferrero S, Arcaini L, Pulsoni A, Musuraca G, Califano C, Merli M, Bari A, Conconi A, Giudice ID, Re F, Stefani PM, Usai SV, Perrone T, Gini G, Falini B, Gattei V, Manni M, Ladetto M, Mannina D, Federico M. RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.80_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- S. Luminari
- Azienda Unità Sanitaria Locale IRCCS Arcispedale Santa Maria Nuova IRCCS Hematology Unit and University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Reggio Emilia Italy
| | - S. Galimberti
- University of Pisa Department of Clinical and Experimental Medicine Pisa Italy
| | - A. Versari
- Azienda Unità Sanitaria Locale‐IRCCS ‐ Arcispedale Santa Maria Nuova Medicina Nucleare Reggio Emilia Italy
| | - A. Tucci
- ASST Spedali Civili di Brescia SC Ematologia Brescia Italy
| | - C. Boccomini
- A.O.U. Città della Salute e della Scienza di Torino SC Ematologia Torino Italy
| | - L. Farina
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology Milano Italy
| | - F. Zaja
- Università degli Studi di Trieste Dipartimento Clinico di Scienze mediche, chirurgiche e della salute and, Azienda Sanitaria Universitaria Giuliano Isontina SC Ematologia Trieste Italy
| | | | - S. Ferrero
- University of Torino, Hematology Department of Molecular Biotechnologies and Health Sciences and AOU “Città della Salute e della Scienza di Torino” Hematology 1 Torino Italy
| | - L. Arcaini
- Fondazione IRCCS Policlinico San Matteo di Pavia Division of Hematology and University of Pavia Department of Molecular Medicine Pavia Italy
| | - A. Pulsoni
- Sapienza Università di Roma Dipartimento di Biotecnologie Cellulari ed Ematologia Roma Italy
| | - G. Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Department of Hematology Meldola Italy
| | - C. Califano
- Ospedale Umberto I, U.O Medicina‐Oncoematologia Nocera Inferiore Italy
| | - M. Merli
- University Hospital Ospedale di Circolo e Fondazione Macchi ASST Settelaghi Varese Italy
| | - A. Bari
- Università di Modena e Reggio Emilia Dipartimento di Scienze Mediche e Chirurgiche Materno‐Infantili e dell'Adulto Modena Italy
| | - A. Conconi
- Ospedale degli Infermi Unit of Hematology Biella Italy
| | - I. del Giudice
- Policlinico Umberto I ‐ Università "La Sapienza" ‐ Istituto Ematologia Dipartimento di Medicina Traslazionale e di Precisione Roma Italy
| | - F. Re
- Azienda Ospedaliero Universitaria di Parma UO Ematologia e CTMO Parma Italy
| | - P. M. Stefani
- General Hospital Ca' Foncello Hematology Treviso Italy
| | - S. V. Usai
- Ospedale Oncologico Armando Businco Division of Hematology Cagliari Italy
| | - T. Perrone
- University of Bari Hematology Bari Italy
| | - G. Gini
- Marche Polytechnic University Department of Clinical and Molecular Sciences, Hematology Ancona Italy
| | - B. Falini
- Ospedale S. Maria della Misericordia University of Perugia Institute of Hematology and CREO (Center for Hemato‐Oncological Research) Perugia Italy
| | - V. Gattei
- Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Clinical and Experimental Onco‐Hematology Unit Aviano Italy
| | - M. Manni
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Modena Italy
| | - M. Ladetto
- Università del Piemonte Orientale Dipartimento di Medicina Traslazionale and AO SS Antonio e Biagio e Cesare Arrigo SC Ematologia Alessandria Italy
| | - D. Mannina
- Azienda Ospedaliera Papardo UOC di Ematologia Messina Italy
| | - M. Federico
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Modena Italy
| |
Collapse
|
6
|
Martelli M, Zucca E, Botto B, Kryachok I, Ceriani L, Balzarotti M, Tucci A, Cabras MG, Zilioli VR, Rusconi C, Angrilli F, Arcaini L, Iwanicka AD, Ferreri A, Merli F, Zhao W, Hodgson D, Ionescu C, Fosså A, Cwynarski K, Mikhaeel G, Jerkeman M, Janikova A, Hüttmann A, Ciccone G, Metser U, Barrington S, Malkowski B, Versari A, Esposito F, Cozens K, Ielmini N, Ricardi R, Cavalli F, Johnson P, Davies A. IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.49_2879] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
7
|
Luminari S, Guerra L, Durmo R, Chauvie S, Peano S, Franceschetto A, Fallanca F, Tarantino V, Pinto A, Ghiggi C, Pulsoni A, Merli M, Farina L, Tani M, Botto B, Musuraca G, Falini B, Ballerini F, Stefani PM, Bolis S, Pietrantuono G, Manni M, Marcheselli L, Federico M, Versari A. EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.33_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S. Luminari
- Azienda Unità Sanitaria Locale IRCCS Arcispedale Santa Maria Nuova IRCCS, Hematology Unit and University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Reggio Emilia Italy
| | - L. Guerra
- S. Gerardo Hospital University of Milano‐Bicocca, Nuclear Medicine and , University of Milano Bicocca School of Medicine and Surgery Monza Italy
| | - R. Durmo
- Azienda USL‐IRCCS di Reggio Emilia Nuclear Medicine Reggio Emilia Italy
| | - S. Chauvie
- Santa Croce e Carle Hospital Department of Medical Physics Cuneo Italy
| | - S. Peano
- ASO S. Croce e Carle S.C. Medicina Nucleare Cuneo Italy
| | - A. Franceschetto
- Modena Cancer Center University of Modena and Reggio Emilia Department of Oncology and Hematology Unit of Nuclear Medicine Modena Italy
| | - F. Fallanca
- IRCCS San Raffaele Scientific Institute Nuclear Medicine Unit Milano Italy
| | - V. Tarantino
- University of Modena and Reggio Emilia PhD program in Clinical and Experimental Medicine (CEM) Modena Italy
| | - A. Pinto
- National Cancer Institute Fondazione "G. Pascale" IRCCS Hematology‐Oncology and Stem Cell Transplantation Unit Napoli Italy
| | - C. Ghiggi
- IRCCS San Martino Hospital Hematology and Transplant Center Division Genoa Italy
| | - A. Pulsoni
- Sapienza Università di Roma Dipartimento di Biotecnologie Cellulari ed Ematologia Roma Italy
| | - M. Merli
- University Hospital Ospedale di Circolo e Fondazione Macchi ASST Settelaghi Varese Italy
| | - L. Farina
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology Milano Italy
| | - M. Tani
- Ospedale Civile S Maria delle Croci Azienda Unità Sanitaria Locale (AUSL) Ravenna Italy
| | - B. Botto
- A.O.U. Città della Salute e della Scienza di Torino SC Ematologia Torino Italy
| | - G. Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Department of Hematology Meldola Italy
| | - B. Falini
- University of Perugia, Institute of Hematology and CREO (Center for Hemato‐Oncological Research) Ospedale S. Maria della Misericordia Perugia Italy
| | - F. Ballerini
- IRCCS Ospedale Policlinico San Martino University of Genoa Clinica Ematologica Genova Italy
| | - P. M. Stefani
- General Hospital Ca' Foncello Hematology Treviso Italy
| | - S. Bolis
- ASST MONZA, SC di Ematologia Monza Italy
| | - G. Pietrantuono
- IRCCS Centro di Riferimento Oncologico della Basilicata Hematology and Stem Cell Transplantation Unit Rionero in Vulture Italy
| | - M. Manni
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Modena Italy
| | | | - M. Federico
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Modena Italy
| | - A. Versari
- Azienda USL‐IRCCS di Reggio Emilia Nuclear Medicine Reggio Emilia Italy
| |
Collapse
|
8
|
Galli E, Muratore F, Boiardi L, Casali MI, Versari A, Besutti G, Spaggiari L, Mancuso P, Giorgi Rossi P, Salvarani C. OP0069 THE ROLE OF POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) IN DISEASE ACTIVITY ASSESSMENT IN PATIENTS WITH LARGE VESSEL VASCULITIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Assessment of disease activity in large vessel vasculitis (LVV) is still an unmet need. PET Vascular Activity Score (PETVAS) is a new composite score aimed at quantifying the overall inflammatory burden by adding together PET qualitative visual scores (0-3, according to Meller) in nine selected arterial regions (1). In two independent cohorts, PETVAS showed to be effective in discriminating between patients with clinically active and inactive vasculitis.Objectives:To assess the role of PET/CT and the performance of PETVAS in differentiating between clinically active and inactive vasculitis in a single center cohort of patients with LVV.Methods:One-hundred patients with radiographic evidence of LVV were enrolled by the Rheumatology Unit of Reggio Emilia Hospital (Italy) between June 2007 and September 2020. All subjects underwent full clinical, laboratory and imaging evaluation (including PET/CT) at baseline, annually and when a relapse was suspected. Medical records of recruited patients were retrospectively reviewed from baseline visit until 30 September 2020, last follow-up or death.For each PET/CT test, the nuclear medicine physician’s interpretation of scans (active/inactive vasculitis) was compared with disease activity clinical judgement (active disease/remission). The latter was based on comprehensive signs/symptoms assessment, laboratory and imaging (excluding PET/CT) data and was considered the reference standard.For each PET/CT scan, PETVAS score was calculated and its performance in discriminating between patients with active and inactive disease was compared to clinical judgement.Results:In the study period 100 LVV patients [51 giant cell arteritis (GCA), 49 Takayasu arteritis (TAK)] underwent a total of 474 PET scans. Nuclear medicine physician’s interpretation of PET/CT was able to discriminate between patients in clinically active LVV (n 167) and those in clinical remission (n 307) with a sensitivity of 60% (95% CI, 51 to 69%) and a specificity of 80% (95% CI, 75 to 84%). The following sensitivity and specificity values were found in LVV subgroups: 73% (95% CI, 59 to 84%) and 77% (95% CI, 70 to 83%) for TAK, and 51% (95% CI, 38 to 63%) and 82% (95% CI, 76 to 88%) for GCA, respectively.LVV patients with higher PETVAS scores were more frequently classified as having active disease: age and sex adjusted OR 1.15 (95% CI, 1.11 to 1.19), p<0.0001. Similar results were found in LVV subgroups, [age and sex adjusted OR 1.12 (95% CI, 1.08 to 1.17) for GCA and 1.22 (95% CI, 1.14 to 1.31) for TAK, all p<0.0001].The area under receiver operating characteristics (ROC) curve (AUC) of PETVAS in differentiating between clinically active and inactive LVV was 0.73 (95% CI, 0.68 to 0.79). Similar results were found in LVV subgroups, [0.70 (95% CI, 0.62 to 0.78) for GCA, and 0.79 (95% CI, 0.71 to 0.87) for TAK]. A PETVAS ≥10 provided 61% sensitivity and 80% specificity in differentiating between clinically active and inactive LVV (52% sensitivity and 82% specificity in GCA subgroup and 73% sensitivity and 78% specificity in TAK subgroup).Conclusion:In our cohort PET/CT has shown to be useful in monitoring LVV disease activity.PETVAS seems to be a reliable tool in helping clinicians to discriminate between LVV patients with active disease and those in remission.References:[1]Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, Malayeri AA, Merkel PA, Novakovich E, Bluemke DA, Ahlman MA. 18 F-Fluorodeoxyglucose-Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis. Arthritis Rheumatol. 2018 Mar;70(3):439-449. doi: 10.1002/art.40379. Epub 2018 Feb 6. PMID: 29145713; PMCID: PMC5882488.Disclosure of Interests:None declared
Collapse
|
9
|
Panzuto F, Maccauro M, Campana D, Faggiano A, Massironi S, Pusceddu S, Spada F, Ferone D, Modica R, Grana CM, Ferolla P, Rinzivillo M, Badalamenti G, Zatelli MC, Gelsomino F, De Carlo E, Bartolomei M, Brizzi MP, Cingarlini S, Versari A, Fanciulli G, Arvat E, Merola E, Cives M, Tafuto S, Baldari S, Falconi M. Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet). J Endocrinol Invest 2021; 44:989-994. [PMID: 32803662 PMCID: PMC7429140 DOI: 10.1007/s40618-020-01393-4] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Accepted: 08/09/2020] [Indexed: 02/08/2023]
Abstract
INTRODUCTION The organization of the healthcare system has significantly changed after the recent COVID-19 outbreak, with a negative impact on the management of oncological patients. The present survey reports data collected by the Italian Association for Neuroendocrine Tumors on the management of patients with neuroendocrine neoplasia (NEN) during the pandemic dissemination. METHODS A survey with 57 questions was sent to NEN-dedicated Italian centers regarding the management of patients in the period March 9, 2020, to May 9, 2020 RESULTS: The main modification in the centers' activity consisted of decreases in newly diagnosed NEN patients (- 76.8%), decreases in performed surgical procedures (- 58%), delays to starting peptide receptor radionuclide therapy (45.5%), postponed/canceled follow-up examinations (26%), and canceled multidisciplinary teams' activity (20.8%). A low proportion of centers (< 10%) reported having to withdraw systemic anti-tumor medical treatment due to concerns about the pandemic situation, whereas PRRT was withdrawn from no patients. CONCLUSION Although the COVID-19 outbreak induced the centers to reduce some important activities in the management of NEN patients, the Italian network was able to provide continuity in care without withdrawing anti-tumor treatment for the majority of patients.
Collapse
Affiliation(s)
- F Panzuto
- Digestive Disease Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189, Rome, Italy.
| | - M Maccauro
- Nuclear Medicine Unit, ENETS Center of Excellence, IRRCS National Cancer Institute (INT), Milan, Italy
| | - D Campana
- Division of Oncology, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - A Faggiano
- Endocrinology Unit, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
| | - S Massironi
- Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
- European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy
| | - S Pusceddu
- Oncology Unit, ENETS Center of Excellence, IRRCS National Cancer Institute (INT), Milan, Italy
| | - F Spada
- Oncology Unit, ENETS Center of Excellence, European Cancer Institute (IEO), Milan, Italy
| | - D Ferone
- Endocrinology Unit, IRCCS Ospedale Policlinico San Martino; Endocrinology, Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genoa, Italy
| | - R Modica
- Department of Clinical Medicine and Surgery, University "Federico II", Naples, Italy
| | - C M Grana
- Nuclear Medicine Division, IRCCS European Institute of Oncology, Milan, Italy
| | - P Ferolla
- Multidisciplinary Group for Diagnosis and Treatment of Neuroendocrine Tumors Umbria Regional Cancer Network, Perugia, Italy
| | - M Rinzivillo
- Digestive Disease Unit, ENETS Center of Excellence, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189, Rome, Italy
| | - G Badalamenti
- Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy
| | - M C Zatelli
- Section of Endocrinology and Internal Medicine,, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - F Gelsomino
- Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy
| | - E De Carlo
- Department of Medicine, Internal Medicine III, University of Padova, Padua, Italy
| | - M Bartolomei
- Nuclear Medicine Department, Sant'Anna Hospital, Ferrara, Italy
| | - M P Brizzi
- Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy
| | - S Cingarlini
- Oncology Unit, ENETS Center of Excellence, University Hospital of Verona, Verona, Italy
| | - A Versari
- Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS of Reggio Emilia, Reggio Emilia, Italy
| | - G Fanciulli
- NET Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari - Endocrine Unit, AOU Sassari, Sassari, Italy
| | - E Arvat
- Oncological Endocrinology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - E Merola
- Department of Gastroenterology, Azienda Provinciale per i Servizi Sanitari di Trento (APSS), Trento, Italy
| | - M Cives
- Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy
| | - S Tafuto
- S.C. Sarcomi e Tumori Rari, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy
| | - S Baldari
- Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, University of Messina, Messina, Italy
| | - M Falconi
- Pancreatic Surgery, ENETS Center of Excellence, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy
| |
Collapse
|
10
|
Nanni A, Ricci A, Versari A, Messori M. Wine derived additives as poly(butylene succinate) (PBS) natural stabilizers for different degradative environments. Polym Degrad Stab 2020. [DOI: 10.1016/j.polymdegradstab.2020.109381] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Tintori A, Cerbara L, Ciancimino G, Crescimbene M, La Longa F, Versari A. Adaptive behavioural coping strategies as reaction to COVID-19 social distancing in Italy. Eur Rev Med Pharmacol Sci 2020; 24:10860-10866. [PMID: 33155248 DOI: 10.26355/eurrev_202010_23449] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Social distancing, as experienced by the Italian population during the COVID-19 outbreak, generated the long-term activation of stress-response in individuals. This has been a crucial opportunity to study the coping strategies that people put in place to adapt their lives and habits to such a unique condition. For this reason, we have investigated both emotion-focused and problem-oriented coping strategies among the Italian population by relating them to other structural factors, such as social, economic and cultural conditions. MATERIALS AND METHODS More than 140,000 online interviews were collected in Italy from March 22 to April 2, 2020. This large dataset was used to carry out multivariate statistical data analysis with the aim of creating behavioral profiles, starting from coping parameters and other information. This technique has produced an association, showing a good level of statistical significance, between coping strategies and reactions to social distancing, due to the health emergency, during the data collection phase. RESULTS Two coping indicators - problem-oriented and focused on positive emotions coping strategies - were selected as objective variables in a "decision tree" modelling. The results have shown a link between individual factors (i.e., atmosphere at home) and educational and social factors (i.e., compliance with restrictions during the health emergency). CONCLUSIONS The reduction of social interaction had quite a significant impact on people's behavior; furthermore, coping strategies have played a crucial role in facing this stressor. For both the selected coping indicators, the best predictor was the atmosphere perceived at home. Moreover, the respondents' previous experiences have played a relevant role in the acceptance of new rules imposed by the government. This information can be useful in planning future social policies, both at national and international level, during such peculiar times.
Collapse
Affiliation(s)
- A Tintori
- Institute for Research on Population and Social Policies of the National Research Council of Italy (CNR-Irpps), Rome, Italy.
| | | | | | | | | | | |
Collapse
|
12
|
Bertolini V, Palmieri A, Bassi MC, Bertolini M, Trojani V, Piccagli V, Fioroni F, Cavuto S, Guberti M, Versari A, Cola S. CT protocol optimisation in PET/CT: a systematic review. EJNMMI Phys 2020; 7:17. [PMID: 32180029 PMCID: PMC7076098 DOI: 10.1186/s40658-020-00287-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2019] [Accepted: 03/10/2020] [Indexed: 12/26/2022] Open
Abstract
Purpose Currently, no consistent guidelines for CT scans used within PET/CT examinations are available. This systematic review provides an up-to-date overview of studies to answer the following questions: What are the specific CT protocols used in PET/CT? What are the possible purposes of requiring a CT study within a PET/CT scan? Is the CT protocol obtained from a dosimetric optimisation study? Materials and method PubMed/MEDLINE, Cochrane Library, Embase and Scopus were systematically searched for relevant studies in accordance with the PRISMA statement. The literature search was conducted from January 2007 until June 2019. Data derived from studies were standardized in order to reduce possible biases, and they were divided into clinically homogeneous subgroups (adult, child or phantom). Subsequently, we divided the CT protocol intents into 3 types (anatomic localization only, attenuation correction only and diagnostic purpose). A narrative approach was used to summarise datasets and to investigate their heterogeneity (due to medical prescription methodology) and their combination in multiseries CT protocols. When weighted computed tomography dose index (CTDIw) was available, we calculated the volumetric computed tomography dose index (CTDIvol) using the pitch value to make the results uniform. Eventually, the correlation between protocol intents and CTDIvol values was obtained using a Kruskal–Wallis one-way ANOVA statistical test. Result Starting from a total of 1440 retrieved records, twenty-four studies were eligible for inclusion in addition to two large multicentric works that we used to compare the results. We analyzed 87 CT protocols. There was a considerable range of variation in the acquisition parameters: tube current–time product revealed to have the most variable range, which was 10–300 mAs for adults and 10–80 mAs for paediatric patients. Seventy percent of datasets presented scans acquired with tube current modulation, 9% used fixed tube current and in 21% of them, this information was not available. Dependence between mean CTDIvol values and protocol intent was statistically significant (p = 0.002). As expected, in diagnostic protocols, there was a statistically significant difference between CTDIvol values of with and without contrast acquisitions (11.68 mGy vs 7.99 mGy, p = 0.009). In 13 out of 87 studies, the optimisation aim was not reported; in 2 papers, a clinical protocol was used; and in 11 works, a dose optimisation protocol was applied. Conclusions According to this review, the dose optimisation in PET/CT exams depends heavily on the correct implementation of the CT protocol. In addition to this, considering the latest technology advances (i.e. iterative algorithms development), we suggest a periodic quality control audit to stay updated on new clinical utility modalities and to achieve a shared standardisation of clinical protocols. In conclusion, this study pointed out the necessity to better identify the specific CT protocol use within PET/CT scans, taking into account the continuous development of new technologies.
Collapse
Affiliation(s)
- V Bertolini
- Medical Physics Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - A Palmieri
- Nuclear Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - M C Bassi
- Medical Library, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - M Bertolini
- Medical Physics Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
| | - V Trojani
- Medical Physics Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.,Medical Physics Specialization School, Università degli Studi di Bologna, Bologna, Italy
| | - V Piccagli
- Medical Physics Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - F Fioroni
- Medical Physics Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - S Cavuto
- Research and Statistics Infrastructure, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - M Guberti
- Health Care Professionals Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - A Versari
- Nuclear Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| | - S Cola
- Nuclear Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy
| |
Collapse
|
13
|
Lococo F, Rena O, Torricelli F, Filice A, Di Stefano T, Rapicetta C, Coruzzi C, Boldorini R, Ciarrocchi A, Versari A, Paci M. P1.06-10 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Diagnostic/Prognostic Performance and Correlation with Pathological Results. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.997] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Federico M, Mannina D, Versari A, Ferrero S, Marcheselli L, Boccomini C, Dondi A, Tucci A, Guerra L, Galimberti S, Cavallo F, Olivieri J, Corradini P, Arcaini L, Chauvie S, Del Giudice I, Rusconi C, Pinto A, Molinari A, Pulsoni A, Merli M, Kovalchuk S, Nassi L, Bolis S, Gattei V, Manni M, Pileri S, Brugiatelli M, Luminari S. RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI. Hematol Oncol 2019. [DOI: 10.1002/hon.110_2629] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Federico
- Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche; University of Modena and Reggio Emilia; Modena Italy
| | - D. Mannina
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - A. Versari
- Nuclear Medicine Unit; AUSL-IRCCS of Reggio Emilia; Reggio Emilia Italy
| | - S. Ferrero
- Department of Molecular Biotechnologies and Health Sciences, Division of Hematology; University of Torino; Torino Italy
| | - L. Marcheselli
- Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto; Fondazione Italiana Linfomi; Modena Italy
| | - C. Boccomini
- SC Ematologia; AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Dondi
- Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto; Fondazione Italiana Linfomi; Modena Italy
| | - A. Tucci
- SC Ematologia; ASST-Spedali Civili; Brescia Italy
| | - L. Guerra
- Nuclear Medicine Unit; San Gerardo Hospital; Monza Italy
| | - S. Galimberti
- Division of Hematology, Department of Oncology; Santa Chiara Hospital; Pisa Italy
| | - F. Cavallo
- Division of Hematology; University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino; Torino Italy
| | - J. Olivieri
- Clinica Ematologica; Centro Trapianti e Terapie Cellulari “C. Melzi”, DAME, ASUI; Udine Italy
| | - P. Corradini
- Department of Oncology and Hematology; Fondazione Istituto Nazionale dei Tumori Milano University of Milano; Milano Italy
| | - L. Arcaini
- Department of Molecular Medicine; University of Pavia, Division of Hematology, Fondazione IRCCS Policlinico S. Matteo; Pavia Italy
| | - S. Chauvie
- Medical Physics Unit; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - I. Del Giudice
- Hematology Unit, Department of Translational and Precision Medicine; Sapienza University of Rome; Roma Italy
| | - C. Rusconi
- Division of Hematology; ASST Grande ospedale Metropolitano Niguarda; Milano Italy
| | - A. Pinto
- Department of Hematology and Developmental Therapeutics; Istituto Nazionale Tumori, Fondazione ‘G. Pascale’ IRCCS; Napoli Italy
| | - A. Molinari
- UO Ematologia; OC Rimini AUSL Romagna; Rimini Italy
| | - A. Pulsoni
- Hematology Unit, Department of Translational and Precision Medicine; Sapienza University of Rome; Roma Italy
| | - M. Merli
- Hematology; University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria; Varese Italy
| | - S. Kovalchuk
- Ematologia; Università degli Studi di Firenze; Firenze Italy
| | - L. Nassi
- Hematology; AOU Maggiore della Carità; Novara Italy
| | - S. Bolis
- Hematolgy Unit; ASST-Monza; Monza Italy
| | - V. Gattei
- Clinical and Experimental Onco-Haematology Unit; Centro di Riferimento Oncologico, IRCCS; Aviano Italy
| | - M. Manni
- Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche; University of Modena and Reggio Emilia; Modena Italy
| | - S. Pileri
- Divisione di Diagnosi Ematopatologica; Istituto Europeo di Oncologia; Milano Italy
| | - M. Brugiatelli
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - S. Luminari
- S.C. Ematologia; Arcispedale S. Maria Nuova-IRCCS; Reggio Emilia Italy
| |
Collapse
|
15
|
Guerra L, Bergesio F, Versari A, Franceschetto A, Peano S, Fallanca F, Storto G, Luminari S, Rigacci L, Gallamini A, Federico M, Chauvie S. INTERIM ANALYSIS OF CENTRAL REVIEW OF END-OF-THERAPY PET IN FOLL12 TRIAL FOR FOLLICULAR LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.62_2631] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- L. Guerra
- Nuclear Medicine; San Gerardo Hospital - ASST Monza; Monza Italy
| | - F. Bergesio
- Medical Physics; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - A. Versari
- Nuclear Medicine; AUSL-IRCCS of Reggio Emilia; Reggio Emilia Italy
| | - A. Franceschetto
- Nuclear Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - S. Peano
- Nuclear Medicine; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - F. Fallanca
- Nuclear Medicine; San Raffaele Scientific Institute; Milano Italy
| | - G. Storto
- Nuclear Medicine; IRCCS-CROB Referral Cancer Center of Basilicata; Rionero in Vulture Italy
| | - S. Luminari
- Department of Diagnostic Medicine; Clinical and Public Health, University of Modena and Reggio Emilia; Modena Italy
| | - L. Rigacci
- Haematology and Stem Cells Transplantation Unit; San Camillo Forlanini Hospital; Roma Italy
| | - A. Gallamini
- Research and Clinical Innovation; Antoine Lacassagne Cancer Center; Nice France
| | - M. Federico
- CHIMOMO; University of Modena and Reggio Emilia; Modena Italy
| | - S. Chauvie
- Medical Physics; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| |
Collapse
|
16
|
Finocchiaro D, Ferri V, Grassi E, Fioroni F, Guidi G, Sergi F, Castellani G, Versari A, Iori M. 142. DoseFX: A software for dosimetry of organs and lesions in molecular radiotherapy. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
17
|
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R. Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 2018; 59:90-101. [PMID: 29110129 DOI: 10.1007/s12020-017-1455-6] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2017] [Accepted: 10/10/2017] [Indexed: 12/21/2022]
Abstract
PURPOSE AND PATIENTS The M.O.S.CA.TI. (Metastases of the Skeleton from CArcinoma of the ThyroId) is a multicenter, retrospective study investigating the real-life outcome and management of bone metastases (BM) in 143 patients (63 M, 80 F; median age 64 years, range 11-87) with differentiated thyroid carcinoma (DTC). RESULTS Radio-active iodine (RAI) treatment was performed in 131 patients (91.6%), surgical approach and/or external radiotherapy in 68 patients (47.6%), and anti-resorptive bone-active drugs in 32 patients (22.4%; in 31 zoledronate and in one denosumab). At the start of treatment, 24 patients (75.0%) receiving anti-resorptive bone-active drugs had at least one clinical skeletal-related event (SRE) (p < 0.001). One or more clinical SREs (pathological fractures and/or malignant hypercalcemia and/or spinal cord compression) developed in 53 patients (37.1%). Development of SREs was significantly associated with metachronous BM (hazard ratio (HR) 2.04; p = 0.04), localization of BM to cervical spine (HR 3.89; p = 0.01), and lack of avid RAI uptake (HR 2.66; p = 0.02). Thirty-nine patients (27.3%) died in correlation with development of SREs (HR 6.97; p = 0.006) and localization of BM to the hip (HR 3.86; p = 0.02). Moreover, overall mortality was significantly decreased by RAI therapy (HR 0.10; p = 0.02), whereas no significant effects were induced by bone-active drugs (p = 0.36), external radiotherapy (p = 0.54), and surgery (p = 0.43) of BM. CONCLUSIONS SREs are very frequent in BM from DTC and they impact patient survival. In the real life, the use of bone-active drugs is currently limited to zoledronate in patients with pre-existing SREs. In this clinical setting, RAI therapy, but not zoledronate, decreased mortality.
Collapse
Affiliation(s)
- G Mazziotti
- Endocrine Unit, ASST Carlo Poma, Mantua, Italy
| | - A M Formenti
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
| | - M B Panarotto
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
- Nuclear Medicine, University of Brescia, Brescia, Italy
| | - E Arvat
- Oncological Endocrinology, University of Turin, Torino, Italy
| | - A Chiti
- Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy
- Humanitas University, Milan, Italy
| | - A Cuocolo
- Nuclear Medicine, University of Naples Federico II, Napoli, Italy
| | - M E Dottorini
- Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy
| | - C Durante
- Internal Medicine, University Sapienza of Rome, Roma, Italy
| | - L Agate
- Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Filetti
- Internal Medicine, University Sapienza of Rome, Roma, Italy
| | - F Felicetti
- Oncological Endocrinology, University of Turin, Torino, Italy
| | - A Filice
- Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - L Pace
- Department of Medicine and Surgery, University of Salerno, Fisciano, Italy
| | - T Pellegrino
- Institute of Biostructure and Bioimaging of the National Research Council of Italy-CNR, Naples, Italy
| | - M Rodari
- Nuclear Medicine, Humanitas Research Hospital and Humanitas University, Milan, Italy
| | - M Salvatori
- Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy
| | - C Tranfaglia
- Nuclear Medicine, "S. Maria della Misericordia" Hospital, Perugia, Italy
| | - A Versari
- Nuclear Medicine, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Reggio Emilia, Italy
| | - D Viola
- Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Frara
- San Raffaele Vita-Salute University, Milan, Italy
| | - A Berruti
- Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy
| | - A Giustina
- San Raffaele Vita-Salute University, Milan, Italy.
| | - R Giubbini
- Nuclear Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
- Nuclear Medicine, University of Brescia, Brescia, Italy
| |
Collapse
|
18
|
Cottereau A, Versari A, Loft A, Casasnovas R, Bellei M, Ricci R, Bardet S, Castagnoli A, Brice P, Raemaekers J, Deau B, Fortpied C, Raveloarivahy T, Girinsky T, Van Zele E, Vander Borght T, Federico M, Hutchings M, Ricardi U, Andre M, Meignan M. PROGNOSTIC VALUE OF BASELINE TOTAL METABOLIC TUMOR VOLUME (TMTV) FOR PATIENTS WITH EARLY STAGE HODGKIN LYMPHOMA ENROLLED IN THE STANDARD ARM OF THE H10 (EORTC/LYSA/FIL) TRIAL. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_16] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- A. Cottereau
- Nuclear Medicine department; Tenon Hospital; Paris France
| | - A. Versari
- Nuclear Medicine; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Italy
| | - A. Loft
- Dep. of Clinical Physiology, Nuclear Medicine, Rigshospitalet; Copenhagen University Hospital; Copenhagen Denmark
| | - R. Casasnovas
- Hematology; CHU le Bocage, and INSERM, LNC URM866; Dijon France
| | - M. Bellei
- Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - R. Ricci
- LYSA Imaging, LYSARC; Henri Mondor Hospital; Creteil France
| | - S. Bardet
- Nuclear Medicine; CLCC François Baclesse; Caen France
| | - A. Castagnoli
- Nuclear Medicine; Ospedale Santo Stefano; Prato Italy
| | - P. Brice
- Hematology; Saint-Louis Hospital, APHP; Paris France
| | - J. Raemaekers
- Hematology; Radboud University Medical Cente; Nijmegen Netherlands
| | - B. Deau
- Hematology; Cochin Hospital, APHP; Paris France
| | - C. Fortpied
- Statistics; European Organization for Research and Treatment of Cancer; Brussels Belgium
| | - T. Raveloarivahy
- Hematology; European Organisation for Research and Treatment of Cancer; Brussels Belgium
| | - T. Girinsky
- Radiation oncology; Institut Gustave Roussy; Villejuif France
| | - E. Van Zele
- LYSA Imaging, LYSARC; Henri Mondor Hospital; Creteil France
| | - T. Vander Borght
- Nuclear Medicine; Université Catholique de Louvain IMRE/MINT CHU Mont-Godinne; Yvoir Belgium
| | - M. Federico
- Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - M. Hutchings
- Hematology Department, Rigshospitalet; Copenhagen University Hospital; Copenhagen Denmark
| | - U. Ricardi
- Oncology; AO Città della Salute e della Scienza; Torino Italy
| | - M. Andre
- Hematology; Université catholique de Louvain, CHU UCL Namur; Yvoir Belgium
| | - M. Meignan
- LYSA Imaging; Henri Mondor University Hospitals; Creteil France
| |
Collapse
|
19
|
Cottereau A, Versari A, Dupuis J, Chartier L, Menga M, Casasnovas R, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J, Meignan M. PROGNOSTIC MODEL FOR HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA INCLUDING BASELINE TOTAL METABOLIC TUMOR VOLUME AND END INDUCTION PET: a POOLED ANALYSIS FROM LYSA AND FIL TRIALS. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- A. Cottereau
- Nuclear Medicine Department; Tenon Hospital; Paris France
| | - A. Versari
- Nuclear Medicine Department; Santa Maria Nuova Hospital; Reggio Emilia Italy
| | - J. Dupuis
- Hematology Department, Lymphoid Malignancies Unit; Henri Mondor Hospital; Créteil France
| | - L. Chartier
- Department of Biostatistics; Centre Hospitalier Lyon Sud, Pierre Bénite, LYSARC; Pierre-Bénite France
| | - M. Menga
- Nuclear Medicine Department; Santa Maria Nuova Hospital; Reggio Emilia Italy
| | | | - C. Haioun
- Hematology Department, Lymphoid Malignancies Unit; Henri Mondor Hospital; Créteil France
| | - H. Tilly
- Hematology Department, UMR918, Centre Henri Becquerel; Université de Rouen; Rouen France
| | - V. Tarantino
- Nuclear Medicine Department; Santa Maria Nuova Hospital; Reggio Emilia Italy
| | - J. Dubreuil
- Nuclear Medicine Department, Centre Hospitalier Lyon Sud, Pierre Bénite; Pierre Benite France
| | - M. Federico
- Hematology; University of Modena and Reggio Emilia; Modena Italy
| | - G. Salles
- Hematology Department; Hospices Civils de Lyon 1, Université Claude Bernard Lyon 1; Pierre Benite France
| | - S. Luminari
- Hematology Department, Santa Maria Nuova Hospital, IRCCS; University of Modena and Reggio Emilia; Modena Italy
| | - J. Trotman
- Haematology Department, Concord Hospital; University of Sydney; Sydney Australia
| | - M. Meignan
- LYSA Imaging; Henri Mondor University Hospitals; Creteil France
| |
Collapse
|
20
|
Vezzali L, Versari A, Cadamuro A, Trifiletti E, Di Bernardo GA. Out-group threats and distress as antecedents of common in-group identity among majority and minority group members in the aftermath of a natural disaster. Int J Psychol 2016; 53:417-425. [DOI: 10.1002/ijop.12406] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Accepted: 11/02/2016] [Indexed: 11/08/2022]
Affiliation(s)
- Loris Vezzali
- Dipartimento di Educazione e Scienze Umane; University of Modena and Reggio Emilia; Modena Italy
| | - Annalisa Versari
- Dipartimento di Educazione e Scienze Umane; University of Modena and Reggio Emilia; Modena Italy
| | - Alessia Cadamuro
- Dipartimento di Educazione e Scienze Umane; University of Modena and Reggio Emilia; Modena Italy
| | - Elena Trifiletti
- Department of Philosophy, Education and Psychology; University of Verona; Verona Italy
| | - Gian Antonio Di Bernardo
- Dipartimento di Educazione e Scienze Umane; University of Modena and Reggio Emilia; Modena Italy
| |
Collapse
|
21
|
Sollini M, Muratore F, Roncali M, Erba PA, Salvarani C, Versari A. Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT. Acta Reumatol Port 2016; 41:268. [PMID: 27771731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
|
22
|
Soriano A, Pazzola G, Boiardi L, Muratore F, Macchioni P, Aldigeri R, Casali M, Versari A, Salvarani C. SAT0340 Distinct Distribution Patterns of Large Vessel Vasculitis Assessed with 18f-FDG PET/CT: A Cluster and Principal Component Analysis Study. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.5576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
23
|
Addimanda O, Pulsatelli L, Boiardi L, Assirelli E, Pazzola G, Muratore F, Dolzani P, Versari A, Casali M, Magnani L, Bottazzi B, Mantovani A, Salvarani C, Meliconi R. AB0051 Angiogenic and Anti-Angiogenic Factors: Biomarkers for Large Vessel Vasculitis? Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2437] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Feliciani G, Fama A, Ciammella P, Fioroni F, Casali M, Elisa B, Podgornii A, Versari A, Merli F, Iori M. EP-1864: A 18FDG-PET texture analysis study on early stage Hodgkin Lymphoma patient outcome prediction. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33115-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
25
|
Donnarumma R, Bocci V, Capparella E, Collamati F, Cremonesi M, Ferrari M, Fioroni F, Grana C, Ioannidis G, Iori M, Limiti G, Mancini Terracciano C, Marafini M, Morganti S, Russomando A, Solfaroli Camilloci E, Toppi M, Traini G, Versari A, Faccini R. A novel radioguided surgery technique exploiting beta – decay. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.362] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
26
|
Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bellò M, Rambaldi I, Tacchetti P, Hillengass J, Gamberi B, Pantani L, Magarotto V, Versari A, Offidani M, Zannetti B, Carobolante F, Balma M, Musto P, Rensi M, Mancuso K, Dimitrakopoulou-Strauss A, Chauviè S, Rocchi S, Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M. 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease. Leukemia 2015; 30:417-22. [DOI: 10.1038/leu.2015.291] [Citation(s) in RCA: 106] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2015] [Revised: 09/17/2015] [Accepted: 09/29/2015] [Indexed: 12/29/2022]
|
27
|
Sollini M, Taralli S, Milella M, Erba P, Rubagotti S, Fraternali A, Roncali M, Moscarella E, Perotti G, Rufini V, Versari A. Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma. J Eur Acad Dermatol Venereol 2015; 30:1507-11. [DOI: 10.1111/jdv.13405] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Accepted: 08/05/2015] [Indexed: 11/30/2022]
Affiliation(s)
- M. Sollini
- Nuclear Medicine Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| | - S. Taralli
- Institute of Nuclear Medicine; Università Cattolica del Sacro Cuore; Rome Italy
| | - M. Milella
- Division of Medical Oncology; Regina Elena National Cancer Institute; Rome Italy
| | - P.A. Erba
- Regional Center of Nuclear Medicine; University of Pisa; Pisa Italy
| | - S. Rubagotti
- Nuclear Medicine Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| | - A. Fraternali
- Nuclear Medicine Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| | - M. Roncali
- Nuclear Medicine Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| | - E. Moscarella
- Skin Cancer Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| | - G. Perotti
- Institute of Nuclear Medicine; Università Cattolica del Sacro Cuore; Rome Italy
| | - V. Rufini
- Institute of Nuclear Medicine; Università Cattolica del Sacro Cuore; Rome Italy
| | - A. Versari
- Nuclear Medicine Unit; Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Reggio Emilia Italy
| |
Collapse
|
28
|
Paganelli G, Rossetti C, Aglietta M, Messina C, Versari A, Michalski J, O'Sullivan J, Parker C, Garcia-Vargas J, Sartor A, Finkelstein S. External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv341.31] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Amadori D, Rossetti C, Aglietta M, Messina C, Versari A, Vogelzang N, Sartor A, Coleman R, Govi S, Fang F, Skjorestad I, Nilsson S, Parker C. 3-year safety follow-up of radium-223 dichloride (Ra-223) in patients (Pts) with castration resistant prostate cancer (CRPC) and symptomatic bone metastases (Mets) from ALSYMPCA. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv341.07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Cadamuro A, Versari A, Vezzali L, Trifiletti E. Preventing the detrimental effect of posttraumatic stress in young children: The role of theory of mind in the aftermath of a natural disaster. European Journal of Developmental Psychology 2015. [DOI: 10.1080/17405629.2015.1055240] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
31
|
Vezzali L, Drury J, Versari A, Cadamuro A. Sharing distress increases helping and contact intentions via social identification and inclusion of the other in the self: Children’s prosocial behaviour after an earthquake. Group Processes & Intergroup Relations 2015. [DOI: 10.1177/1368430215590492] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We surveyed young children ( N = 517) affected by two major earthquakes to shed light on the role of identity processes in relation to the common observation that disasters can bring survivors closer together and enhance helping amongst them. As expected, posttraumatic stress symptoms caused by the earthquake were positively associated with intentions to have contact with and help other survivors of the earthquake, these effects being sequentially mediated by inclusion of the other in the self and by one-group representation. These findings extend previous research on both the antecedents and the behavioural effects of identity-fusion. The results are also the first quantitative test of a social identity account of collective resilience in children. We argue that these findings have practical as well as theoretical significance, as they demonstrate the adaptive function of group processes in informal responses to disasters.
Collapse
|
32
|
Pazzola G, Casali M, Muratore F, Pipitone N, Boiardi L, Aldigeri R, Versari A, Salvarani C. FRI0262 The Role of 18F-FDG-PET/CT in the Diagnosis and Follow-Up of Large Vessel Vasculitis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
33
|
Kirienko M, Sollini M, Lopci E, Versari A, Chiti A. Applications of PET imaging with radiolabelled choline (11C/18F-choline). Q J Nucl Med Mol Imaging 2015; 59:83-94. [PMID: 25677590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The use of radiopharmaceuticals is the distinguishing characteristics of nuclear medicine. Among the panel of available radiopharmaceuticals in many PET centers around the world, choline is well represented, being widely used to image prostate cancer. Carbon-11 labelled choline can only be produced in centres with a cyclotron available, but the 18F-labelled radiopharmaceutical is distributed and licensed in several countries in Europe. Besides prostate cancer, other possible uses of choline are related to its ability to indirectly evaluate the cell proliferation as a measure of the synthesis of lipids required for cell membrane. In particular, the radiopharmaceutical can be successfully used in those districts where 18F-FDG has a high uptake, like the brain. Moreover, slow growing tumors, not always taking up 18F-FDG, like hepatocellular carcinoma, can also be imaged. We will evaluate possibly uses of this molecule in patients affected by prostate cancer, brain tumors and hepatocellular carcinoma.
Collapse
Affiliation(s)
- M Kirienko
- Department of Nuclear Medicine, Milano‑Bicocca University, Milan, Italy, 2 Nuclear Medicine Unit, Department of Oncology and Advanced Technology, Arcispedale Santa Maria Nuova, IRCCS, Reggio Emilia, Italy -
| | | | | | | | | |
Collapse
|
34
|
Sollini M, Zanichelli M, Roncali M, Atti G, Erba P, Versari A. Combined imaging approach to diagnose a meningioma in a patient with prostate and lung cancers. Rev Esp Med Nucl Imagen Mol 2015. [DOI: 10.1016/j.remnie.2014.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
35
|
Grassi E, Fioroni F, Ferri V, Mezzenga E, Sarti MA, Paulus T, Lanconelli N, Filice A, Versari A, Iori M. Quantitative comparison between the commercial software STRATOS(®) by Philips and a homemade software for voxel-dosimetry in radiopeptide therapy. Phys Med 2014; 31:72-9. [PMID: 25457430 DOI: 10.1016/j.ejmp.2014.10.002] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Revised: 10/02/2014] [Accepted: 10/05/2014] [Indexed: 10/24/2022] Open
Abstract
BACKGROUND Targeted radionuclide therapy is a rapidly growing modality. A few commercial treatment planning systems are entering the market. However, some in-house systems are currently developed for a more flexible and customized dosimetry calculation at voxel-level. For this purpose, we developed a novel software, VoxelMed, and performed a comparison with the software STRATOS. METHODS The validation of both of them was undertaken using radioactive phantoms with different volume inserts. A cohort of 10 patients was also studied after a therapeutic administration of (177)Lu-labelled radiopeptides. The activity, number of disintegrations, absorbed dose and dose-volume histogram (DVH) were calculated for the phantoms and the kidneys in patients, which were the main critical organs at risk in this study. RESULTS In phantoms the absorbed doses computed with VoxelMed and STRATOS agree within 5%. In patients at the voxel-level the absorbed dose to kidneys (VoxelMed: mean 0.66 Gy/GBq) showed a limited difference of 5%, but with a remarkable range (-40%, +60%) between the two software packages. Voxel-dosimetry allows to estimate the dose non-homogeneities in volumes, which may be evaluated through DVHs. CONCLUSION This study demonstrates that a fully 3D voxel-dosimetry with multiple SPECT images is feasible by using home-made or commercial software package and absorbed dose results obtained are similar. The main difference between the studied tools was observed in the activity integration method (effective vs physical half-time to time activity curve tail). We believe that an effective half-time integration method produces a more accurate approximation of clinical uptake and resultant dosimetry.
Collapse
Affiliation(s)
- E Grassi
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy.
| | - F Fioroni
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - V Ferri
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - E Mezzenga
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - M A Sarti
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - T Paulus
- Philips Technologie GmbH Innovative Technologies, Pauwelsstr. 17, 52074 Aachen, Germany
| | - N Lanconelli
- Dept. of Physics, University of Bologna, I-40126 Bologna, Italy
| | - A Filice
- Nuclear Medicine Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - A Versari
- Nuclear Medicine Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| | - M Iori
- Medical Physics Dept., IRCCS - S. Maria Nuova Hospital, Viale Risorgimento 80, I-42123 Reggio Emilia, Italy
| |
Collapse
|
36
|
Vezzali L, Cadamuro A, Versari A, Giovannini D, Trifiletti E. Feeling like a group after a natural disaster: Common ingroup identity and relations with outgroup victims among majority and minority young children. Br J Soc Psychol 2014; 54:519-38. [PMID: 25330995 DOI: 10.1111/bjso.12091] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2014] [Revised: 09/17/2014] [Indexed: 11/27/2022]
Abstract
We conducted a field study to test whether the common ingroup identity model (Gaertner & Dovidio, 2000, reducing intergroup bias: The common ingroup identity model. Philadelphia, PA: Psychology Press) could be a useful tool to improve intergroup relations in the aftermath of a natural disaster. Participants were majority (Italian) and minority (immigrant) elementary school children (N = 517) living in the area struck by powerful earthquakes in May 2012. Results revealed that, among majority children, the perceived external threat represented by the earthquake was associated with greater perceptions of belonging to a common ingroup including both ingroup and outgroup. In turn, heightened one-group perceptions were associated with greater willingness to meet and help outgroup victims, both directly and indirectly via more positive outgroup attitudes. Among immigrant children, perceived disaster threat was not associated with any of the dependent variables; one-group perceptions were positively associated with outgroup attitudes, helping and contact intentions towards outgroup victims. Thus, one-group perceptions after a natural disaster may promote more positive and supporting relations between the majority and the minority group. We discuss the theoretical and practical implications of the findings.
Collapse
Affiliation(s)
- Loris Vezzali
- Department of Education and Humanities, University of Modena and Reggio Emilia, Italy
| | - Alessia Cadamuro
- Department of Education and Humanities, University of Modena and Reggio Emilia, Italy
| | - Annalisa Versari
- Department of Education and Humanities, University of Modena and Reggio Emilia, Italy
| | - Dino Giovannini
- Department of Education and Humanities, University of Modena and Reggio Emilia, Italy
| | - Elena Trifiletti
- Department of Philosophy, Education and Psychology, University of Verona, Italy
| |
Collapse
|
37
|
Luminari S, Biasoli I, Versari A, Rattotti S, Bottelli C, Rusconi C, Merli F, Spina M, Ferreri A, Zinzani P, Gallamini A, Franceschetto A, Boccomini C, Franceschetti S, Salvi F, Raimondo F, Carella A, Micol Q, Balzarotti M, Musto P, Federico M. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Ann Oncol 2014; 25:442-7. [DOI: 10.1093/annonc/mdt562] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Possemato N, Macchioni P, Germano G, Pipitone N, Versari A, Salvarani C. Clinical images: PET-CT and contrast-enhanced ultrasound in Takayasu's arteritis. Rheumatology (Oxford) 2013; 53:447. [DOI: 10.1093/rheumatology/ket332] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F, Spina M, Ferreri A, Zinzani P, Gallamini A, Mastronardi S, Boccomini C, Gaidano G, D'Arco A, Di Raimondo F, Carella A, Santoro A, Musto P, Federico M. The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol 2013; 24:2108-12. [DOI: 10.1093/annonc/mdt137] [Citation(s) in RCA: 109] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
|
40
|
Catanoso M, Magnani L, Spaggiari L, Pipitone N, Caruso A, Addimanda O, Meliconi R, Pulsatelli L, Versari A, Boiardi L, Vaglio A, Pattacini P, Salvarani C. AB0816 Efficacy of biological agents in the treatment of idiopathic retroperitoneal fibrosis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Giulia P, Muratore F, Casali M, Boiardi L, Macchioni P, Pipitone N, Versari A, Salvarani C. SAT0167 Vascular Standardized Uptake Value of FDG-PET/CT Correlates with Indices of LVV Activity. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
42
|
Pazzola G, Magnani L, Boiardi L, Pipitone N, Muratore F, Versari A, Formisano D, Addimanda O, Meliconi R, Pulsatelli L, Bajocchi G, Catanoso M, Padovano I, Possemato N, Lo Gullo A, Salvarani C. OP0306 Evaluation of Disease Activity Using FDG PET-CT in Patients with Large Vessel Vasculitis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
43
|
Iori M, Cagni E, Orlandi M, Botti A, Versari A, Iotti C, Panicucci B. PO-0833: Voxel-based dose-painting with a commercial treatment planning system by using two different planning methods. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33139-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Pazzola G, Padovano I, Boiardi L, Versari A, Pipitone N, Catanoso M, Pulsatelli L, Meliconi R, Salvarani C. Tocilizumab in glucocorticoid-naïve large-vessel vasculitis. Clin Exp Rheumatol 2013; 31:S59-S61. [PMID: 23306184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2012] [Accepted: 06/13/2012] [Indexed: 06/01/2023]
Abstract
Glucocorticoids (GC) are the mainstay of treatment of large-vessel vasculitis (LVV), but a sizeable number of patients relapse upon tapering the GC dose or after discontinuation of GC therapy. In addition, GC cause numerous adverse events. Therefore, in patients with longstanding disease and in those at risk for GC-related adverse events, the use of alternative therapeutic agents should be considered. Interleukin-6 (IL-6) is a key player in the pathogenesis of LVV. Preliminary data suggest the efficacy of the IL-6 receptor inhibitor tocilizumab (TCZ) in patients with LVV. We report 2 treatment-naïve patients with a recent diagnosis of LVV who received monthly TCZ infusions (8 mg/kg body weight) for 6 consecutive months as monotherapy because of relative contraindications and patients' reluctance to take GC. In both cases we observed a complete clinical response and normalisation of inflammatory markers as well as a decrease in vascular FDG uptake and SUV ratio on fluorodeoxyglucose positron emission/computerised tomography. Serum IL-6 and soluble IL-6 receptor (sIL-6R) levels rose in both patients after TCZ therapy. TCZ may be an effective alternative to GC treatment for LVV patients at risk for GC-related adverse events. Larger studies are required to confirm our findings.
Collapse
Affiliation(s)
- G Pazzola
- Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto e Cura a Carattere Scientifico, Reggio Emilia, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Addimanda O, Spaggiari L, Pipitone N, Versari A, Pattacini P, Salvarani C. Pulmonary artery involvement in Takayasu arteritis. PET/CT versus CT angiography. Clin Exp Rheumatol 2013; 31:S3-S4. [PMID: 23343750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2012] [Accepted: 09/26/2012] [Indexed: 06/01/2023]
Abstract
OBJECTIVES To report a patient with Takayasu arteritis in whom 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computerised tomography (CT) failed to demonstrate pulmonary artery involvement. METHODS A patient with Takayasu arteritis underwent PET/CT and CT angiography before and one year after immunosuppressive treatment. RESULTS Before treatment, PET/CT showed increased FDG uptake in the aortic arch and epiaortic arteries; pulmonary arteries were not visualised. Follow-up PET/CT one year later demonstrated resolution of abnormal vascular FDG uptake. CT angiography of the chest/abdomen prior to treatment revealed circumferential thickening of the ascending aorta, aortic arch, supra-aortic branches, and left inferior intralobar pulmonary artery with normal lumen diameter (27 mm). After therapy, CT angiography revealed decreased aortic wall thickening with complete resolution of intralobar wall thickening. However, the lumen of the central pulmonary artery was increased (32 mm). CONCLUSIONS PET/CT is very sensitive in depicting active vasculitis, but cannot visualise the pulmonary arteries, presumably because their diameter is below the power of detection of PET/CT. CT angiography or magnetic resonance angiography is required to evaluate pulmonary artery abnormalities.
Collapse
Affiliation(s)
- O Addimanda
- Rheumatology Unit, Azienda Ospedaliera di Reggio Emilia, IRCCS, Reggio Emilia, Italy
| | | | | | | | | | | |
Collapse
|
46
|
Treglia G, Versari A, Giovanella L, Pipitone N, Salvarani C. Is 18F-FDG PET a 'potentially hazardous' or an effective tool in evaluating patients with large-vessel vasculitis? Clin Exp Rheumatol 2013; 31:S93. [PMID: 23380155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2012] [Accepted: 01/15/2013] [Indexed: 06/01/2023]
|
47
|
Iori M, Orlandi M, Cagni E, Botti A, Mezzenga E, D'Errico V, Iotti C, Versari A. Voxel-based Dose-painting With a Commercial Treatment Planning System by Using 2 Different Planning Methods. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
48
|
Magnani L, Versari A, Salvo D, Casali M, Germanò G, Meliconi R, Pulsatelli L, Formisano D, Bajocchi G, Pipitone N, Boiardi L, Salvarani C. [Disease activity assessment in large vessel vasculitis]. Reumatismo 2011; 63:86-90. [PMID: 21776444 DOI: 10.4081/reumatismo.2011.86] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Disease activity assessment in large vessel vasculitis (LVV) is often challenging for physicians. In this study, we compared the assessment of disease activity based on inflammatory markers, clinical indices (Indian Takayasu Activity Score [ITAS] and the Kerr/National Institute of Health indices [Kerr/NIH]), and 18F-Fluorodesossiglucose (FGD) vascular uptake at positron emission tomography (Pet). We found that Pet results did not statistically correlate with the clinical indices ITAS and Kerr/NIH, because FDG uptake was increased (grade>2 on a 0-3 scale in at least one evaluated vascular segment) in many patients with inactive disease according to clinical and laboratory parameters (i.e., negative ITAS and Kerr/NIH indices as well as normal erythrocyte sedimentation rate (ESR) and C-reactive protein (PCR)). Similarly, interleukin- 6 and its soluble receptor did not statistically correlate with disease activity. In contrast, clinical indices showed a significant correlation between each other and with inflammatory markers (VES and PCR). These data suggest that while clinical indices and inflammatory markers may be useful to assess disease activity, Pet may be more sensitive.
Collapse
Affiliation(s)
- L Magnani
- Struttura Complessa di Reumatologia, Arcispedale S. Maria Nuova, Viale Risorgimento 80, Reggio Emilia, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
|
50
|
Fioroni F, Iotti C, Paiusco M, Versari A, Grassi E, Salvo D, Iori M. PET/CT and radiotherapy : data transfer, radiotherapy workflow and quality assurance. Q J Nucl Med Mol Imaging 2010; 54:476-489. [PMID: 20927015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
The development of new technologies in radiation therapy has made it possible to introduce more sophisticated techniques that can deliver the prescribed dose with more conformation and accuracy and to apply dose escalation protocols without increasing the risk of healthy tissue damage. This has consented the simultaneous delivery of different dose levels to different parts of the target, making it possible to boost those tumour sub-volumes that are considered more radio resistant. The use of PET for radiotherapy planning purposes has become increasingly important in the last few years, because of its ability to provide valuable biologic and functional data. PET imaging can affect the treatment strategy definition and improve the target delineation and the assessment of therapy response. The most attractive aspect is the perspective to deliver differential doses inside target volumes for areas of different biologic behaviour based on functional imaging, moving closer to the goals of biologically conformal radiation therapy. Each single step of PET/CT-guided radiotherapy workflow, needs to be performed following high standard procedures, within a rigorous and appropriate quality assurance protocol to minimize the sources of errors and to maximize the efficacy of PET imaging in radiation therapy, ensuring safe and effective use of the technology. The present paper focuses on aspects concerning the use of PET/CT in radiation treatment process, with the aim to delineate different possible approaches to its clinical application and to highlight the critical aspects of the various subprocesses.
Collapse
Affiliation(s)
- F Fioroni
- Department of Medical Physics, S. Maria Nuova Hospital, Reggio Emilia, Italy.
| | | | | | | | | | | | | |
Collapse
|